Table 2.
List of target SNPs inside cancer-relevant genes analyzed by direct sequencing in breast cancer and control samples together with an example of interacting miRNA.
GENE | SNP | Allelic Variants | Genomic Position | INTERACTING miR | Active Allele | MFE | MFE change |
---|---|---|---|---|---|---|---|
BRCA1 | rs799917 | C/T | exonic | miR-638^,# | C | −27.52 | −8% |
MDM2 | rs769412 | A/G | exonic | miR-296-5p | G | −18.15 | 66% |
TGFBR1 | rs334348 | A/G | 3′UTR | miR-628-5p^,# | G | −20.95 | 29% |
TP53BP2 | rs17739 | C/T | 3′UTR | miR-129-5p | T | −19.31 | 121% |
TP53INP1 | rs7760 | G/T | 3′UTR | miR-330-5p | G | −17.92 | −92% |
XIAP | rs28382751 | A/C | 3′UTR | miR-542-5p^ | C | −21.25 | 28% |
For each target SNP, an example of computational prediction of MFE percentage change with a selected miRNA is shown.
SNP::miR interactions tested by luciferase assay (Fig 3a and Supplemental Fig 3), and
SNP::miR interactions tested by Western blot (Fig. 3b).